H ypoxia is one of the most potent stimuli for the formation of new blood vessels (angiogenesis), and it mediates vasodilation of vessels, thereby improving tissue perfusion. 1 Lung vessels, however, react to acute hypoxia with constriction rather than dilation, in part through upregulation of vasoactive substances. [2] [3] [4] Furthermore, hypoxia causes pulmonary vascular cells to proliferate in contrast to the usual growth-suppressive effect of hypoxia on many other cell types. [2] [3] [4] [5] [6] On prolonged hypoxia, pulmonary vessels undergo significant structural changes involving medial thickening of arteries caused by smooth muscle cell accumulation and matrix deposition and extension of a muscular wall in intra-acinar vessels. 7 The latter may result from increased proliferation of smooth muscle cells to more distal uncovered vessels or from recruitment and differentiation of pulmonary fibroblasts or pericytes to contractile smooth muscle cells. Another characteristic feature of vascular remodeling during pulmonary hypertension involves rarefaction of pulmonary arteries. 8 Although poorly understood, rarefaction presumably reflects an adaptive structural response to prune insufficiently perfused "ghost" arterioles formed after severe microvascular constriction. 9 As a consequence, pulmonary hypertension and right ventricular hypertrophy may develop, ultimately progressing to right heart failure. This constitutes a major cause of cardiopulmonary morbidity and mortality, for example, in patients with chronic obstructive lung disease, for which few medical treatments exist.
The precise molecular mechanisms that play a role in the pathogenesis of pulmonary hypertension and the structural changes in the pulmonary vasculature are only partly known. 10 Pulmonary vasoconstriction appears to be of importance, and both endothelin and angiotensin have been implicated as important mediators. [11] [12] [13] [14] In contrast, the observation that mice deficient in endothelial nitric oxide synthase (eNOS) were found to develop excessive pulmonary hypertension, 15 whereas adenoviral NOS gene transfer prevented hypoxia-induced pulmonary hypertension 16 point to an important role of NO in the prevention of hypoxia-induced pulmonary vasoconstriction. In addition, several vascular cell mitogens such as heparin-binding epidermal growth factor, 17 vascular endothelial cell growth factor, 18 and platelet-derived growth factor 19 appear to be implicated in the pathogenesis of pulmonary hypertension. Last, activation of proteases, in particular elastase, may be essential for extracellular matrix degradation associated with pulmonary vascular remodeling. 20 Elastase was also shown to be able to induce the release of growth factors (such as basic fibroblast growth factor [b-FGF]) from the extracellular matrix, which may further contribute to pulmonary artery smooth muscle proliferation. 21 Several observations point to an additional role of the plasminogen system in pulmonary hypertension. Similar to the role of elastase in extracellular matrix remodeling, there is evidence suggesting that enhanced plasmin proteolysis may contribute to pulmonary vascular remodeling. Indeed, hypoxia increases expression of u-PAR (the cellular receptor of urokinase-type plasminogen activator [u-PA], enhances plasma fibrinolytic activity, and upregulates expression of plasminogen (plg) activators during ventricular hypertrophy in response to hypoxia or overloading. [22] [23] [24] Interestingly, and also similar to elastase, plasmin has been shown to induce the release of b-FGF from the extracellular matrix. 25 To further investigate the role of the plasminogen system in the pathogenesis of pulmonary hypertension and right ventricular remodeling, mice with specific deficiencies in plasminogen, tissue-type plasminogen activator (t-PA), u-PA, or u-PAR were subjected to hypoxic conditions. The present findings implicate an important role of u-PA-mediated plasmin proteolysis in hypoxia-induced pulmonary vascular remodeling and subsequent right ventricular hypertrophy, which potentially might have important consequences for future therapeutic strategies in patients with (evolving) pulmonary hypertension.
Methods

Animals and Experimental Protocol
The experiments were approved by the institutional review board and were conducted according to the guidelines for animal experiments of the National Institutes of Health. Transgenic mice and appropriate wild-type control mice were studied after being exposed to chronic hypoxia, as compared with normoxic conditions (controls). Experimental groups (nϭ11 to 14) consisted of the following adult (6 to 8 weeks old) mice: (1) t-PA Ϫ/Ϫ mice, 26 (2) u-PA Ϫ/Ϫ mice, 26 (3) u-PAR Ϫ/Ϫ mice, 27 (4) plasminogen Ϫ/Ϫ mice, 28 and (5) wild-type mice. In addition, newborn (pϩ7) u-PA Ϫ/Ϫ , t-PA Ϫ/Ϫ , and wild-type mice were studied. Mice were placed in a tightly sealed chamber under normobaric hypoxia (FIO 2 10%). Genotypic identical normoxic control mice were maintained in identical conditions in room air (FIO 2 21%).
Hemodynamic Measurements
The right ventricular systolic and diastolic pressures were measured in anesthetized mice (sodium pentobarbital, 60 mg/kg IP) by transthoracic puncture. 29 Right ventricular pressure was measured continuously for 5 minutes with a pressure transducer (model AA 016, Baxter). Systemic arterial blood pressure was continuously measured over a 5-minute period by insertion of the needle into the abdominal aorta. Hemodynamic measurements were displayed on an oscilloscope (Pressure Amplifier 863, Elema) and analyzed on a PC-based computer program (Windaq Software version 1.37, Dataq Instruments Inc).
Blood Sampling and Hematocrit Measurement
Blood samples were collected from the abdominal aorta and anticoagulated with EDTA (10 mmol/L). Hematocrit was measured with an automated cell counter (Abbott Cell-Dyn 1330 system).
Measurement of Right Ventricular Hypertrophy
The right ventricular free wall was separated from the left ventricle and septum under a dissection microscope. 30 The right ventricle and the left ventricle/septum were dried at 90°for 72 hours. Right ventricle and left ventricle plus septum were weighed separately. Results are expressed as ratio of right ventricle weight over left ventricle plus septum weight or right ventricle weight over body weight.
Histology and Morphometric Analysis
A cannula was introduced into the right atrium, and mice were perfused with 1% phosphate-buffered paraformaldehyde at 100 cm H 2 O pressure for 5 minutes. Subsequently, the trachea was cannulated and 1% phosphate-buffered paraformaldehyde was perfused at 30 cm H 2 O through the airways. The heart and lungs were removed en bloc, and the heart was separated from the lungs and the large vessels. The samples were cryoembedded or postfixed for 24 hours in 1% phosphate-buffered paraformaldehyde, dehydrated, and embedded in paraffin. Verhoeffs-van Gieson elastica stains were performed on 4-m sections. In addition, sections of the heart (7 m) were used for sirius red staining and immunostaining of laminin, thrombomodulin, t-PA, u-PA, or matrix metalloproteinase-9 (MMP-9). 31, 32 In situ zymographic activity of t-PA and u-PA was performed with gel overlays on 7-m unfixed cryosections. 32 Hypoxia-induced pulmonary vascular remodeling was assessed by two different methods. 34 First, the peripheral vessel density (defined as the number of vessels per 100 alveoli) was determined. Peripheral arteries were defined as all vessels landmarked to airway structures distal to the terminal bronchioli. Nonmuscularized and partly or fully muscularized vessels were scored separately. Second, media thickness was determined by measuring the diameter between the internal and external elastic lamina.
Right ventricular myocyte hypertrophy was measured as the cross-sectional area of Ն50 individual cardiomyocytes per heart in the right ventricle on laminin-stained sections to delineate the basement membrane. The number of subendocardial capillaries was counted on thrombomodulin-stained sections (to visualize endothelial cells) and expressed as number of capillaries per square millimeter. Collagen type I and III contents of the right ventricle were quantified on sirius red-stained sections.
Statistical Analysis
Results are presented as mean values ϮSD. Statistical analysis was performed by ANOVA and subsequent Newman-Keuls test. A value of PϽ0.05 was considered statistically significant.
Results
Hemodynamic Measurements
Adult wild-type mice that were exposed to 28 days of hypoxia showed a significant 1.8-to 2.7-fold rise in right ventricular pressure (Table 1 ). The right ventricular systolic and diastolic pressures were 37Ϯ3.8 mm Hg and 15Ϯ3.7 mm Hg, respectively, as compared with right ventricular systolic and diastolic pressures of 21Ϯ3.2 and 5.5Ϯ1.0 mm Hg in normoxic mice (PϽ0.01). In u-PA Ϫ/Ϫ mice, no such increase in right ventricular pressure was seen. In contrast, t-PA Ϫ/Ϫ mice showed a rise in right ventricular pressure in response to hypoxia that was fully comparable with that of wild-type mice. Mice with a deficiency in the u-PA receptor showed a partial but significant hypoxiainduced enhancement in right ventricular pressure. Plasminogen-deficient mice had no significant increase in right ventricular pressure in response to hypoxia. Hypoxia did not affect mean arterial blood pressure in any of the groups (Table 1) . Hypoxia resulted in an increase in an identical hematocrit from 48.7Ϯ1.0% to 61.1Ϯ0.9%.
Right Ventricular Weight
In wild-type mice, hypoxia caused a 1.7-fold increase in the right ventricle/left ventricleϩseptum ratio and a 1.8-fold increase in the right ventricle weight/body weight ratio (Figure 1 ). In accordance with the right ventricular pressure measurements, u-PA Ϫ/Ϫ and plg Ϫ/Ϫ mice did not show any increase in right ventricular weight, whereas t-PA-deficient mice showed right ventricular hypertrophy that was comparable to wild-type mice. Hypoxia caused a significant increase in right ventricular weight in u-PAR Ϫ/Ϫ mice; however, again this increase was more modest as compared with the increase in wild-type mice (RV/LVϩS ratio in u-PAR Ϫ/Ϫ mice 42Ϯ6% as compared with 51Ϯ5% in wild-type mice, PϽ0.05).
In newborn mice (10 days hypoxia), a similar pattern was observed (Figure 2 ). Both the right ventricle/left ventricleϩseptum ratio and the right ventricle weight/body weight ratio were markedly increased in wild-type mice (1.7-to 1.9-fold) and t-PA Ϫ/Ϫ mice (1.6-to 2.0-fold) exposed to hypoxia. In contrast, u-PA Ϫ/Ϫ mice did not show any significant increase in right ventricular hypertrophy in response to hypoxia. Total body weight was not different between hypoxic and normoxic mice of all different genotypes.
Pulmonary Vascular Remodeling
Hypoxia induced mild vascular rarefaction in the lungs of wild-type mice (Table 2 ). In wild-type mice exposed to hypoxia, a 29% reduction in nonmuscularized vessels and a 22% reduction in partly or fully muscularized arterioles were observed (PϽ0.05). Both u-PA Ϫ/Ϫ mice and plg Ϫ/Ϫ mice did not show such a reduction in vascular density in response to hypoxia. The hypoxia-induced rarefaction in t-PA Ϫ/Ϫ mice was similar to that in wild-type mice. U-PAR Ϫ/Ϫ mice showed an intermediate reduction in the number of arteries per 100 alveoli.
The increase in smooth muscle cells within the distal arterial walls, as reflected by the increase in media thickness, followed a similar pattern. In wild-type mice, hypoxia caused an Ϸ2-fold increase in the ratio of media thickness over vascular diameter, which was similar in t-PA Ϫ/Ϫ mice. Conversely, u-PA Ϫ/Ϫ mice and plg Ϫ/Ϫ mice did not show an increase in media thickness (Table 2 and Figure 3 ). In mice with a deficiency of the u-PA receptor, a significant increase in media thickness was observed, however, to a lesser extent than the increase seen in wild type or t-PA Ϫ/Ϫ mice. Interestingly, hypoxic wild-type or t-PA Ϫ/Ϫ mice showed a marked fragmentation of the elastic membrane, whereas this was not seen in u-PA Ϫ/Ϫ or plg Ϫ/Ϫ mice ( Figure 3 ).
Pulmonary vascular remodeling in response to hypoxia was somewhat more pronounced in newborn wild-type mice (data not shown) but was again completely absent in u-PA Ϫ/Ϫ mice. There were no differences in pulmonary vascular density or media thickness between genotypes at normoxic conditions.
Histological Analysis of Right Ventricular Hypertrophy
Histological analysis revealed a hypoxia-induced increase in right ventricular cardiomyocyte size from 250Ϯ40 m 2 to 340Ϯ68 m 2 in wild-type mice, which was not present in u-PA Ϫ/Ϫ mice (Table 3) . Also, the almost 2-fold increase in collagen content of the right ventricular wall in hypoxic wild-type mice was not seen in u-PA Ϫ/Ϫ mice ( Figure 4 and Table 3 ). Right ventricular remodeling on hypoxia in wildtype mice was associated with a small but nonsignificant reduction in subendocardial capillary density (from 5200Ϯ210 per mm 2 to 4400Ϯ260 per mm 2 ).
Expression and Zymographic Activity of Plasminogen Activators and MMP-9 in Lung and Heart
Immunostaining for u-PA revealed enhanced u-PA expression in lungs of hypoxic wild-type mice, in particular located near vascular smooth muscle cells ( Figure 5 ). Zymographic analysis showed a 1.8Ϯ0.3-fold increase in u-PA activity in these lungs. In addition, there was increased MMP-9 expression (which might be seen as a candidate for u-PA-mediated plasmin formation) 30 related to macrophages, in particular around the pulmonary vasculature. There was no major difference in the expression or zymographic activity of plasminogen activators in hearts from hypoxic mice as compared with hearts from normoxic controls.
Discussion
In this study, the role of the plasminogen/plasmin system in the pathogenesis of hypoxia-induced pulmonary hypertension and right ventricular hypertrophy was investigated. Chronic exposure to hypoxia resulted in increased pulmonary hypertension and right ventricular hypertrophy, 29 associated with a marked remodeling of the pulmonary vasculature, characterized by a vascular rarefaction and an increase in media thickness of peripheral pulmonary arteries. However, u-PA Ϫ/Ϫ and plg Ϫ/Ϫ mice were resistant to these hypoxia-induced anatomical and functional changes, whereas t-PA Ϫ/Ϫ mice responded to hypoxia in an identical manner as wild-type mice. Hypoxic u-PAR Ϫ/Ϫ mice showed an intermediate response, which is significantly lower than wild-type mice. Hence, the plasminogen system is involved in hypoxiainduced pulmonary vascular remodeling and associated functional changes. In particular, u-PA appears to be of essential importance for the development of hypoxia-induced pulmonary hypertension. Because both u-PA Ϫ/Ϫ and plg Ϫ/Ϫ mice showed a similar lack of response to hypoxia, it may be assumed that u-PA acts by conversion of plasminogen to plasmin. The role of u-PA was further substantiated by the demonstration of upregulated u-PA expression and activity in hypoxic lungs. Ample evidence indicates that u-PA-mediated plasmin generation may play a pivotal role in tissue remodeling. [31] [32] [33] It has been demonstrated in vivo that u-PA is essential for arterial neointima formation and adequate wound healing on vascular injury and for left ventricular remodeling after myocardial infarction. 32, 33 In contrast, t-PA, which is the major activator of plasma fibrinolytic activity, did not play an important role in the vascular remodeling and associated changes, which is in line with previous observations in other models. 32, 33 It should be noted that our observations do not exclude that the hypoxia-induced effects are related to a mediator other than hypoxia per se. For example, an increase in cardiac output and changes in hematocrit or vasoconstriction may contribute to the signaling that induced increased u-PA expression.
Although the exact mechanism of the hypoxia-induced changes in the pulmonary vasculature remains to be established, it can be assumed that it at least partly depends on the ability of cells to proliferate across anatomic borders, such as the elastic laminae. The present observation that u-PA Ϫ/Ϫ and plg Ϫ/Ϫ mice did not show hypoxia-induced fragmentation of the elastic membrane may explain the absence of pulmonary vascular remodeling in u-PA-deficient or plg-deficient mice. It is, however, not completely clear which mechanism can be held responsible for the hypoxia-induced rarefaction of pulmonary vessels, which was also less prominent in u-PA Ϫ/Ϫ and plg Ϫ/Ϫ mice. Interestingly, hypoxia-induced pulmonary vascular remodeling was partly reduced in u-PAR-deficient mice as well. This observation indicates that the u-PA-induced effects in response to hypoxia are in part mediated by the u-PA receptor. Because u-PAR is expressed on smooth muscle cells and it has been shown that binding of u-PA to u-PAR may significantly affect smooth muscle cell adhesion to matrix proteins, 34 u-PAR may play an additional supportive though not essential role in the u-PA-mediated response on hypoxia.
Our findings might have some relevance for the management of hypoxic pulmonary hypertension and right ventricular hypertrophy in patients because the murine hypoxia model has generally been accepted as a model for human hypoxic disease. 8, 35 Hypothetically, selective inhibition of u-PA activity or interference in the u-PA binding to the u-PA receptor (although to a lesser extent) might be of benefit for patients with pulmonary vascular disease caused by chronic hypoxia. At present, there is no specific therapy for this condition, and the occurrence of pulmonary vascular disease and secondary right ventricular hypertrophy and subsequent right heart failure is associated with considerable morbidity and mortality. However, further study in other models and in patients with hypoxic pulmonary hypertension is warranted before definitive conclusions regarding a potential therapeutic relevance of the present observations can be made.
Conclusions
Loss of the u-PA or plasminogen gene protects against the development of hypoxia-induced pulmonary hypertension, pulmonary vascular remodeling, and right ventricular hypertrophy. These observations indicate an essential role of the plasminogen system as a mediator of the direct or indirect adaptive responses to chronic hypoxia and in the occurrence of hypoxic pulmonary vascular disease. 
